Stock NOVN NOVARTIS AG
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Novartis AG

Equities

NOVN

CH0012005267

Market Closed - Swiss Exchange
Other stock markets
 09:01:30 26/04/2024 pm IST 		5-day change 1st Jan Change
89.5 CHF -0.56% Intraday chart for Novartis AG +4.64% +5.46%
26/04 NOVARTIS AG : Receives a Buy rating from Jefferies ZD
24/04 BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating MT

Chart calendar Novartis AG

0c7e1dca9b587991083ea53.FrRZ1dFTZ_o1gnm1e7PTl76eecyclw1CCzYV7idYtaw.TNhr4ehjIr9i1h6CPvqB2O_JN_3003wPRgEm3UES-M15hG-KoycxrwHsKA~57e0ad78ff62acfb91bf7663be23df26

Upcoming events on Novartis AG

23/05/2024 Deutsche Bank dbAccess European Champions Conference
02/06/2024 ASCO Meeting
19/06/2024 Citi European Healthcare Conference
20/06/2024 J.P. Morgan European Healthcare Conference
18/07/2024 10:30 am Q2 2024 Earnings Release
29/10/2024 11:30 am Q3 2024 Earnings Release
20/11/2024 Investor Meeting - Day 1
21/11/2024 Investor Meeting - Day 2
29/01/2025 Q4 2024 Earnings Release (Projected)
29/04/2025 Q1 2025 Earnings Release (Projected)
17/07/2025 Q2 2025 Earnings Release (Projected)
28/10/2025 Q3 2025 Earnings Release (Projected)

Past events on Novartis AG

23/04/2024 05:30 pm Q1 2024 Earnings Call
23/04/2024 10:30 am Q1 2024 Earnings Release
07/03/2024 Ex-dividend day for final dividend
05/03/2024 Annual General Meeting
03/03/2024 Muscular Dystrophy Association Clinical and Scientific Conference
31/01/2024 06:30 pm Q4 2023 Earnings Call
31/01/2024 11:30 am Q4 2023 Earnings Release
08/01/2024 10:05 pm JPMorgan Healthcare Conference
08/12/2023 San Antonio Breast Cancer Symposium
28/11/2023 07:00 pm R&D Day
15/11/2023 Wolfe Research Healthcare Conference
15/11/2023 UBS European Conference
14/11/2023 Credit Suisse Healthcare Conference
13/11/2023 09:00 pm Impact and Health Equity Conference
08/11/2023 UBS BioPharma Conference
24/10/2023 05:30 pm Q3 2023 Earnings Call
24/10/2023 04:30 pm ESMO Congress
24/10/2023 10:30 am Q3 2023 Earnings Release
23/10/2023 08:40 pm ESMO Congress
04/10/2023 Spin off

Past dividends on Novartis AG

07/03/2024 Annual 3.3 CHF
04/10/2023 0 CHF
09/03/2023 Annual 3.2 CHF
08/03/2022 Annual 3.1 CHF
04/03/2021 Annual 3 CHF
03/03/2020 Annual 2.95 CHF
09/04/2019 0 CHF
04/03/2019 Annual 2.85 CHF
06/03/2018 Annual 2.8 CHF
02/03/2017 Annual 2.75 CHF

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		47 445
47 897
-0.94%		48 659
49 074
-0.85%		51 626
51 902
-0.53%		50 545
51 352
-1.57%		45 440
46 810
-2.93%
48 785

EBITDA
Million USD		Released
Forecast
Spread 		15 809
15 640
1.08%		16 845
16 496
2.12%		18 246
18 336
-0.49%		18 613
17 036
9.25%		17 937
18 223
-1.57%
19 290

EBIT
Million USD		Released
Forecast
Spread 		14 112
14 152
-0.28%		15 416
15 540
-0.8%		16 588
16 712
-0.74%		16 665
16 417
1.51%		16 372
16 735
-2.17%
18 126

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		8 940
9 963
-10.27%		9 878
10 184
-3%		26 137
18 886
38.39%		8 371
10 562
-20.74%		9 123
10 323
-11.63%
12 843

Net income
Million USD		Released
Forecast
Spread 		7 147
8 481
-15.73%		8 072
8 392
-3.81%		24 021
23 336
2.93%		6 955
8 563
-18.78%		14 854
10 329
43.8%
10 372

EPS
USD		Released
Forecast
Spread 		3,12
3,88
-19.63%		3,55
3,68
-3.52%		10,7
10,3
3.79%		3,19
4,06
-21.46%		7,15
5,38
32.95%
5,06

Announcement Date29/01/2026/01/2102/02/2201/02/2331/01/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		12 531
12 640
-0.86%		12 781
12 767
0.11%		12 543
12 737
-1.52%		12 690
13 138
-3.41%		12 953
12 567
3.07%		13 622
13 270
2.65%		11 782
11 373
3.6%		11 423
11 773
-2.97%		11 829
11 498
2.88%
12 253


12 477


12 766


11 905


12 155

EBITDA
Million USD		Released
Forecast
Spread 		4 407
4 039
9.12%		4 989


4 783
3 239
47.69%		4 473
4 104
8.99%


4 668





4 224
4 775
-11.55%

















EBIT
Million USD		Released
Forecast
Spread 		4 083
4 092
-0.23%		4 270
4 159
2.67%		4 282
4 237
1.06%		4 030
3 741
7.71%		4 413
4 078
8.22%		4 668
4 446
5%		4 405
4 339
1.52%		3 821
4 094
-6.66%		4 537
4 220
7.52%
4 588


4 697


4 542


4 790


4 895

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		2 669
2 838
-5.95%		2 042
2 548
-19.86%		1 919
2 619
-26.73%		1 741
2 521
-30.94%		2 740
2 797
-2.04%		2 769
3 194
-13.31%		1 552
3 240
-52.1%		2 377
3 495
-31.99%		3 129
3 453
-9.38%
3 856


3 880


3 665







Net income
Million USD		Released
Forecast
Spread 		2 222
2 313
-3.93%		1 695
2 340
-27.56%		1 575
2 379
-33.79%		1 466
2 919
-49.78%		2 293
2 268
1.1%		2 316
2 596
-10.8%		1 513
2 786
-45.69%		8 480
6 890
23.08%		2 688
2 459
9.31%
2 777


2 814


2 515







EPS
USD		Released
Forecast
Spread 		1,00
1,04
-3.41%		0,77
1,05
-26.4%		0,73
1,17
-37.81%		0,69
1,35
-48.9%		1,09
1,07
1.82%		1,11
1,26
-11.75%		0,73
1,34
-45.68%		4,14
2,87
44.31%		1,31
1,19
10.18%
1,36


1,39


1,25







Announcement Date26/04/2219/07/2225/10/2201/02/2325/04/2318/07/2324/10/2331/01/2423/04/24-----

Upcoming sector events for Novartis AG

29/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q1 2024 Earnings Release (Projected)
29/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q4 2023 Earnings Release
29/04/2024 BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 AURISCO PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
29/04/2024 PT TEMPO SCAN PACIFIC TBK: Q1 2024 Earnings Release (Projected)
29/04/2024 SICHUAN HUIYU PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
29/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 WEDGE INDUSTRIAL CO.,LTD.: Q1 2024 Earnings Release
More events

Past sector events for Novartis AG

Today LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q4 2023 Earnings Release
Today NANJING VAZYME BIOTECH CO.,LTD: Q4 2023 Earnings Release
Today LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q1 2024 Earnings Release
Today HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
Today ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
Today GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
Today NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
Today ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NOVN Stock
  4. Calendar Novartis AG